Oct 28 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX :
* ENTERED INTO AN EXCLUSIVE INTELLECTUAL PROPERTY LICENCE AGREEMENT WITH GERMAN CANCER RESEARCH CENTER
* AGREEMENT FOR A NOVEL IMAGING TECHNOLOGY IN FIELD OF IMAGE-GUIDED SURGERY FOR PROSTATE CANCER
* UNDER TERMS OF AGREEMENT, CO IS OBLIGED TO PAY DEVELOPMENT MILESTONES AND ROYALTIES ON PRODUCT SALES